The commercial operations of ISTO Technologies, an orthobiologics company, were acquired by private equity firm Thompson Street Capital Partners. Transaction terms were not disclosed.
ISTO's portfolio includes InQu® Bone Graft Extender & Substitute, Influx® Trabecular Bone Graft and CellPoint® Concentrated Bone Marrow Aspirate System.
The company was established in 1997 and began to secure U.S. patents and attract funding shortly thereafter. Thompson Street plans to make investments and complementary acquisitions to support ISTO's product development, salesforce expansion and increase the company’s reach within spine and orthopaedics.
Sources: ISTO Technologies, ORTHOWORLD Inc.
The commercial operations of ISTO Technologies, an orthobiologics company, were acquired by private equity firm Thompson Street Capital Partners. Transaction terms were not disclosed. ISTO's portfolio includes InQu® Bone Graft Extender & Substitute, Influx® Trabecular Bone Graft and CellPoint® Concentrated...
The commercial operations of ISTO Technologies, an orthobiologics company, were acquired by private equity firm Thompson Street Capital Partners. Transaction terms were not disclosed.
ISTO's portfolio includes InQu® Bone Graft Extender & Substitute, Influx® Trabecular Bone Graft and CellPoint® Concentrated Bone Marrow Aspirate System.
The company was established in 1997 and began to secure U.S. patents and attract funding shortly thereafter. Thompson Street plans to make investments and complementary acquisitions to support ISTO's product development, salesforce expansion and increase the company’s reach within spine and orthopaedics.
Sources: ISTO Technologies, ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
